Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- ChecktodayChange DetectedThe page now displays a new Revision: v3.5.5 tag, replacing Revision: v3.5.4, indicating a minor internal update to the site's versioning rather than a change to study details.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small platform update and does not alter the study details or how users interact with the page.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a different release/version of the website interface rather than a change to the clinical trial details.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.